dimarts, 23 de juny del 2015

MassDevice.com +3 | The top 3 medtech stories for June 23, 2015

plus3-1x1

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

 

3. Biosense Webster launches cardiac mapping system

MassDevice.com news

Johnson & Johnson subsidiary Biosense Webster said last Thursday that it launched the Carto 3 system Confidense 3D cardiac mapping module for use during catheter ablation procedures.

The module uses a proprietary algorithm to speed up the process of multi-electrode cardiac mapping, the company said, streamlining a validation process that previously had to be done manually. Read more


2. Glaukos raises the stakes in $99m IPO

MassDevice.com news

Glaukos today raised the proposed price range on its pending initial public offering, saying it will offer 6 million shares at $16 to $17 apiece, which at the midpoint would fetch $99.0 million.

In May, Laguna Hills, Calif.-based Glaukos initially said the offering could gross as much as $86.2 million. Earlier this month the company said it planned to float nearly 5.4 million shares at $13 to $15 apiece, for a midpoint of $75.0 million. Read more


1. Senate eyes the fast track for medical device tax repeal bill

MassDevice.com news

The U.S. Senate yesterday moved to put a bill that would repeal the medical device tax on the fast track , according to The Hill.

Majority leader Sen. Mitch McConnell (R-Ky.) started the process last night by invoking Rule 14 for the bill, which passed the House on a 280-140 vote last week. Forty-six House Democrats voted to approve H.R. 160, the “Protect Medical Innovation Act of 2015,” sponsored by Rep. Erik Paulsen (R-Minn.). Read more

The post MassDevice.com +3 | The top 3 medtech stories for June 23, 2015 appeared first on MassDevice.



from MassDevice http://ift.tt/1HcayEx

Cap comentari:

Publica un comentari a l'entrada